Recombinant Rhesus macaque B7-2/CD86 Protein (His Tag) | PKSQ050070

(No reviews yet) Write a Review
SKU:
575-PKSQ050070
Weight:
1.00 KGS
€535.00
Frequently bought together:

Description

Recombinant Rhesus macaque B7-2/CD86 Protein (His Tag) | PKSQ050070 | Gentaur US, UK & Europe Disrtribition

Synonyms: T-lymphocyte activation antigen CD86 isoform 1;Activation B7-2 antigen; CD86

Active Protein: N/A

Activity: Recombinant Rhesus macaque CD86 is produced by our Mammalian expression system and the target gene encoding Tyr31-Pro247 is expressed with a 6His tag at the C-terminus.

Protein Construction: Recombinant Rhesus macaque CD86 is produced by our Mammalian expression system and the target gene encoding Tyr31-Pro247 is expressed with a 6His tag at the C-terminus.

Fusion Tag: C-His

Species: Rhesus macaque

Expressed Host: Human Cells

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per μg as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 25.7 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Reconstitution: Please refer to the printed manual for detailed information.

Background: T-lymphocyte activation antigen CD86 (B7-2) is a glycosylated protein in the B7 family. B7 family members are transmembrane cell surface molecules that play important roles in immune activation and the maintenance of immune tolerance. It is highly expressed on activated antigen presenting cells. CD86 involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. It may play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. It is expressed by activated B-lymphocytes and monocytes and promoted by MARCH8 and results in endocytosis and lysosomal degradation.

Research Area: N/A

View AllClose